UK markets close in 4 hours 2 minutes

GC Biopharma Corp. (006280.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
113,900.00-3,700.00 (-3.15%)
At close: 03:30PM KST
Currency in KRW
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2276
Avg. Estimate6861,607.52,236.574,501
Low estimate5671,0058343,652
High estimate8052,2103,8405,221
Year ago EPS1551,220-2,3332,236.57
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6688
Avg. Estimate453.5M490.72M1.75B1.86B
Low estimate442.7M463M1.7B1.8B
High estimate464.1M510.1M1.78B1.93B
Year ago salesN/AN/A1.63B1.75B
Sales growth (year/est)N/AN/A7.70%6.50%
Earnings history30/06/202330/09/202331/12/202331/03/2024
Est. EPS1,343.962,425.93-433.5-197.5
Actual EPS1551,220-1,740-2,218
Difference-1,188.96-1,205.93-1,306.5-2,020.5
Surprise %-88.50%-49.70%-301.40%-1,023.00%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate6861,607.52,236.574,501
7 days ago6861,607.52,236.574,501
30 days ago6861,607.51,969.334,393.2
60 days ago884.51,4202,375.294,314.6
90 days ago884.51,4202,0654,314.6
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimates006280.KSIndustrySector(s)S&P 500
Current qtr.342.60%N/AN/AN/A
Next qtr.31.80%N/AN/AN/A
Current year195.90%N/AN/AN/A
Next year101.20%N/AN/AN/A
Next 5 years (per annum)-10.67%N/AN/AN/A
Past 5 years (per annum)-9.96%N/AN/AN/A